DrugPatentWatch Database Preview
Profile for Croatia Patent: P20160447
US Patent Family Members and Approved Drugs for Croatia Patent: P20160447
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | May 4, 2029 | Novartis Pharms Corp | TAFINLAR | dabrafenib mesylate |
➤ Try a Free Trial | Jan 20, 2030 | Novartis Pharms Corp | TAFINLAR | dabrafenib mesylate |
➤ Try a Free Trial | Jan 20, 2030 | Novartis Pharms Corp | TAFINLAR | dabrafenib mesylate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |